Neuroendocrine Tumors and Survival Rates in Multiple Endocrine Neoplasia Type 1 Patients: Impact of Gender Difference
In this MEN-1 cohort, no gender differences in the occurrence of PHPT, PA, DP-NET, lung NET, and thymic NET, nor in survival outcomes including PFS and OS within the DP-NET subcohort, emerged. Therefore, this study supports similar screening and follow-up for both male and female MEN-1 patients.
Authors
- Roberta Modica (ORCID: https://orcid.org/0000-0002-3768-5803)
- Giuseppe Cannavale (ORCID: https://orcid.org/0000-0002-8524-1131)
- Elio Benevento (ORCID: https://orcid.org/0000-0002-4489-3651)
- Roberto Minotta (ORCID: https://orcid.org/0000-0002-8823-0702)
- Annamaria Colao (ORCID: https://orcid.org/0000-0003-4049-2559)
- Alessia Liccardi (ORCID: https://orcid.org/0000-0003-1784-5491)
- Gianfranco Di Iasi (ORCID: https://orcid.org/0009-0001-9737-9912)
Institutions
- Federico II University Hospital (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Neuroendocrinology
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1159/000542143
- Citations
- 4
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.55